| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |